436 related articles for article (PubMed ID: 27436023)
21. [Value of Minimum Apparent Diffusion Coefficient in Peritumoral Edema in the Differential Diagnosis between Primary Central Nervous System Lymphoma and Glioblastoma].
Li MG; Chen ZY; Liu G; Xiao HF; Chen XJ; Lou X; Ma L
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Apr; 40(2):146-150. PubMed ID: 29724302
[TBL] [Abstract][Full Text] [Related]
22. Differentiation of primary central nervous system lymphoma from high-grade glioma and brain metastasis using arterial spin labeling and dynamic contrast-enhanced magnetic resonance imaging.
Xi YB; Kang XW; Wang N; Liu TT; Zhu YQ; Cheng G; Wang K; Li C; Guo F; Yin H
Eur J Radiol; 2019 Mar; 112():59-64. PubMed ID: 30777220
[TBL] [Abstract][Full Text] [Related]
23. Utility of arterial spin labelling MRI for discriminating atypical high-grade glioma from primary central nervous system lymphoma.
Di N; Cheng W; Chen H; Zhai F; Liu Y; Mu X; Chu Z; Lu N; Liu X; Wang B
Clin Radiol; 2019 Feb; 74(2):165.e1-165.e9. PubMed ID: 30415766
[TBL] [Abstract][Full Text] [Related]
24. Differences between primary central nervous system lymphoma and glioblastoma: topographic analysis using voxel-based morphometry.
Yamashita K; Hiwatashi A; Togao O; Kikuchi K; Momosaka D; Hata N; Akagi Y; Suzuki SO; Iwaki T; Iihara K; Honda H
Clin Radiol; 2019 Oct; 74(10):816.e1-816.e8. PubMed ID: 31400805
[TBL] [Abstract][Full Text] [Related]
25. Prognosis prediction of non-enhancing T2 high signal intensity lesions in glioblastoma patients after standard treatment: application of dynamic contrast-enhanced MR imaging.
Kim R; Choi SH; Yun TJ; Lee ST; Park CK; Kim TM; Kim JH; Park SW; Sohn CH; Park SH; Kim IH
Eur Radiol; 2017 Mar; 27(3):1176-1185. PubMed ID: 27357131
[TBL] [Abstract][Full Text] [Related]
26. Differentiation between glioblastoma and primary CNS lymphoma: application of DCE-MRI parameters based on arterial input function obtained from DSC-MRI.
Kang KM; Choi SH; Chul-Kee P; Kim TM; Park SH; Lee JH; Lee ST; Hwang I; Yoo RE; Yun TJ; Kim JH; Sohn CH
Eur Radiol; 2021 Dec; 31(12):9098-9109. PubMed ID: 34003350
[TBL] [Abstract][Full Text] [Related]
27. Glioblastoma and primary central nervous system lymphoma: Preoperative differentiation by using MRI-based 3D texture analysis.
Xiao DD; Yan PF; Wang YX; Osman MS; Zhao HY
Clin Neurol Neurosurg; 2018 Oct; 173():84-90. PubMed ID: 30092408
[TBL] [Abstract][Full Text] [Related]
28. MR imaging based fractal analysis for differentiating primary CNS lymphoma and glioblastoma.
Liu S; Fan X; Zhang C; Wang Z; Li S; Wang Y; Qiu X; Jiang T
Eur Radiol; 2019 Mar; 29(3):1348-1354. PubMed ID: 30167811
[TBL] [Abstract][Full Text] [Related]
29. Recurrent glioblastoma: optimum area under the curve method derived from dynamic contrast-enhanced T1-weighted perfusion MR imaging.
Chung WJ; Kim HS; Kim N; Choi CG; Kim SJ
Radiology; 2013 Nov; 269(2):561-8. PubMed ID: 23878286
[TBL] [Abstract][Full Text] [Related]
30. Differentiation of Primary Central Nervous System Lymphoma From Glioblastoma: Quantitative Analysis Using Arterial Spin Labeling and Diffusion Tensor Imaging.
Abdel Razek AAK; El-Serougy L; Abdelsalam M; Gaballa G; Talaat M
World Neurosurg; 2019 Mar; 123():e303-e309. PubMed ID: 30502475
[TBL] [Abstract][Full Text] [Related]
31. Differentiation between primary CNS lymphoma and atypical glioblastoma according to major genomic alterations using diffusion and susceptibility-weighted MR imaging.
Ozturk K; Soylu E; Cayci Z
Eur J Radiol; 2021 Aug; 141():109784. PubMed ID: 34051685
[TBL] [Abstract][Full Text] [Related]
32. A comparative study of multimodal magnetic resonance in the differential diagnosis of acquired immune deficiency syndrome related primary central nervous system lymphoma and infection.
Li J; Xue M; Yan S; Guan C; Xie R; Chen B
BMC Infect Dis; 2021 Feb; 21(1):165. PubMed ID: 33568094
[TBL] [Abstract][Full Text] [Related]
33. Utility of dynamic contrast-enhanced magnetic resonance imaging for differentiating glioblastoma, primary central nervous system lymphoma and brain metastatic tumor.
Lu S; Gao Q; Yu J; Li Y; Cao P; Shi H; Hong X
Eur J Radiol; 2016 Oct; 85(10):1722-1727. PubMed ID: 27666608
[TBL] [Abstract][Full Text] [Related]
34. Differentiation between Glioblastoma Multiforme and Primary Cerebral Lymphoma: Additional Benefits of Quantitative Diffusion-Weighted MR Imaging.
Ko CC; Tai MH; Li CF; Chen TY; Chen JH; Shu G; Kuo YT; Lee YC
PLoS One; 2016; 11(9):e0162565. PubMed ID: 27631626
[TBL] [Abstract][Full Text] [Related]
35. Machine learning based on multi-parametric magnetic resonance imaging to differentiate glioblastoma multiforme from primary cerebral nervous system lymphoma.
Nakagawa M; Nakaura T; Namimoto T; Kitajima M; Uetani H; Tateishi M; Oda S; Utsunomiya D; Makino K; Nakamura H; Mukasa A; Hirai T; Yamashita Y
Eur J Radiol; 2018 Nov; 108():147-154. PubMed ID: 30396648
[TBL] [Abstract][Full Text] [Related]
36. Comparison between Glioblastoma and Primary Central Nervous System Lymphoma Using MR Image-based Texture Analysis.
Kunimatsu A; Kunimatsu N; Kamiya K; Watadani T; Mori H; Abe O
Magn Reson Med Sci; 2018 Jan; 17(1):50-57. PubMed ID: 28638001
[TBL] [Abstract][Full Text] [Related]
37. Clinical Value of Vascular Permeability Estimates Using Dynamic Susceptibility Contrast MRI: Improved Diagnostic Performance in Distinguishing Hypervascular Primary CNS Lymphoma from Glioblastoma.
Lee B; Park JE; Bjørnerud A; Kim JH; Lee JY; Kim HS
AJNR Am J Neuroradiol; 2018 Aug; 39(8):1415-1422. PubMed ID: 30026384
[TBL] [Abstract][Full Text] [Related]
38. Diffusion radiomics as a diagnostic model for atypical manifestation of primary central nervous system lymphoma: development and multicenter external validation.
Kang D; Park JE; Kim YH; Kim JH; Oh JY; Kim J; Kim Y; Kim ST; Kim HS
Neuro Oncol; 2018 Aug; 20(9):1251-1261. PubMed ID: 29438500
[TBL] [Abstract][Full Text] [Related]
39. Multiparametric-MRI-Based Radiomics Model for Differentiating Primary Central Nervous System Lymphoma From Glioblastoma: Development and Cross-Vendor Validation.
Xia W; Hu B; Li H; Geng C; Wu Q; Yang L; Yin B; Gao X; Li Y; Geng D
J Magn Reson Imaging; 2021 Jan; 53(1):242-250. PubMed ID: 32864825
[TBL] [Abstract][Full Text] [Related]
40. Role of intra-tumoral vasculature imaging features on susceptibility weighted imaging in differentiating primary central nervous system lymphoma from glioblastoma: a multiparametric comparison with pathological validation.
Bhattacharjee R; Gupta M; Singh T; Sharma S; Khanna G; Parvaze SP; Patir R; Vaishya S; Ahlawat S; Singh A; Gupta RK
Neuroradiology; 2022 Sep; 64(9):1801-1818. PubMed ID: 35435463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
